MyAverix Finance
HK · Healthcare
Brii Biosciences Ltd (2137)
Biotechnology
Brii Biosciences Ltd (2137) is listed on HK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $865.41M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 2137
Brii Biosciences Ltd (2137) — FAQ
What is Brii Biosciences Ltd's market cap?
Brii Biosciences Ltd (2137) has a reported market cap of $865.41M (data as of 2026-05-21).
What is 2137's P/E ratio?
The price-to-earnings (P/E) ratio for Brii Biosciences Ltd (2137) is 18.00 (data as of 2026-05-21).
Does Brii Biosciences Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Brii Biosciences Ltd (2137). Check the MyAverix Finance app for the latest dividend data.
What sector is Brii Biosciences Ltd in?
Brii Biosciences Ltd (2137) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 2137 listed on?
2137 is listed on HK.
What is Brii Biosciences Ltd's net margin?
Brii Biosciences Ltd (2137) reports a net margin of 0.0% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.